Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.

McElrath MJ, Ballweber L, Terker A, Kreger A, Sakchalathorn P, Robinson B, Fialkow M, Lentz G, Hladik F.

Antimicrob Agents Chemother. 2010 Feb;54(2):763-72. doi: 10.1128/AAC.00891-09. Epub 2009 Nov 30.

PMID:
19949052
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Clinical development of microbicides for the prevention of HIV infection.

D'Cruz OJ, Uckun FM.

Curr Pharm Des. 2004;10(3):315-36. Review.

PMID:
14754390
[PubMed - indexed for MEDLINE]
3.

Will integrase inhibitors be used as microbicides?

Crucitti GC, Botta M, Di Santo R.

Curr HIV Res. 2012 Jan 1;10(1):36-41. Review.

PMID:
22264044
[PubMed - indexed for MEDLINE]
4.

HIV type 1 integrase inhibitors: from basic research to clinical implications.

Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.

AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.

PMID:
18820719
[PubMed - indexed for MEDLINE]
5.

HIV-1 integration as a target for antiretroviral therapy: a review.

Pluymers W, De Clercq E, Debyser Z.

Curr Drug Targets Infect Disord. 2001 Aug;1(2):133-49. Review.

PMID:
12455410
[PubMed - indexed for MEDLINE]
6.

[The newest developments in anti-HIV-1 drugs].

Zhang XQ.

Yao Xue Xue Bao. 2010 Feb;45(2):194-204. Review. Chinese.

PMID:
21351429
[PubMed - indexed for MEDLINE]
7.

The potential for HIV fusion inhibition.

Cammack N.

Curr Opin Infect Dis. 2001 Feb;14(1):13-6. Review.

PMID:
11979109
[PubMed - indexed for MEDLINE]
8.

HIV-1 integrase and RNase H activities as therapeutic targets.

Andréola ML, De Soultrait VR, Fournier M, Parissi V, Desjobert C, Litvak S.

Expert Opin Ther Targets. 2002 Aug;6(4):433-46. Review.

PMID:
12223059
[PubMed - indexed for MEDLINE]
9.

HIV entry and fusion inhibitors.

Chantry D.

Expert Opin Emerg Drugs. 2004 May;9(1):1-7. Review.

PMID:
15155132
[PubMed - indexed for MEDLINE]
10.

The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.

Pirrone V, Wigdahl B, Krebs FC.

Antiviral Res. 2011 Jun;90(3):168-82. doi: 10.1016/j.antiviral.2011.03.176. Epub 2011 Mar 23. Review.

PMID:
21439325
[PubMed - indexed for MEDLINE]
11.

In search of authentic inhibitors of HIV-1 integration.

Debyser Z, Cherepanov P, Van Maele B, De Clercq E, Witvrouw M.

Antivir Chem Chemother. 2002 Jan;13(1):1-15. Review.

PMID:
12180645
[PubMed - indexed for MEDLINE]
12.

Microbicides: a new hope for HIV prevention.

Nutan, Gupta SK.

Indian J Med Res. 2011 Dec;134(6):939-49. doi: 10.4103/0971-5916.92639. Review.

PMID:
22310826
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

Arribas JR.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:53-9. Review. Spanish.

PMID:
19572427
[PubMed - indexed for MEDLINE]
14.

HIV entry inhibitors: a new generation of antiretroviral drugs.

Krambovitis E, Porichis F, Spandidos DA.

Acta Pharmacol Sin. 2005 Oct;26(10):1165-73. Review.

PMID:
16174430
[PubMed - indexed for MEDLINE]
Free Article
15.

Topical microbicides for prevention of sexually transmitted infections.

Obiero J, Mwethera PG, Wiysonge CS.

Cochrane Database Syst Rev. 2012 Jun 13;6:CD007961. doi: 10.1002/14651858.CD007961.pub2. Review.

PMID:
22696373
[PubMed - indexed for MEDLINE]
16.

[The current progress in the development of HIV-1 fusion inhibitors].

Shi WG, Jia QY, Liu KL.

Yao Xue Xue Bao. 2010 Feb;45(2):184-93. Review. Chinese.

PMID:
21351428
[PubMed - indexed for MEDLINE]
17.

New developments in anti-HIV chemotherapy.

De Clercq E.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):258-75. Review.

PMID:
12084468
[PubMed - indexed for MEDLINE]
18.

Microbicides for multidrug-resistant and multitropic HIV-1.

D'Cruz OJ, Uckun FM.

Curr Opin Investig Drugs. 2008 Feb;9(2):152-69. Review.

PMID:
18246518
[PubMed - indexed for MEDLINE]
19.

A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20).

Manfredi R, Sabbatani S.

Curr Med Chem. 2006;13(20):2369-84. Review.

PMID:
16918361
[PubMed - indexed for MEDLINE]
20.

Emerging drug targets for antiretroviral therapy.

Reeves JD, Piefer AJ.

Drugs. 2005;65(13):1747-66. Review.

PMID:
16114975
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk